But what impact did it actually deliver?
Global pharmaceutical companies spend millions every year creating, sponsoring and attending medical conferences. Yet for decades, the industry has struggled to answer one fundamental question:
What impact did that investment actually deliver?
The most commercially significant moments in the pharmaceutical calendar.
Medical conferences are where pivotal clinical trial data is revealed, innovation surfaced, scientific narratives are established and competitive leadership is won or lost.
The way data is received influences clinical confidence, investor sentiment, future commercial returns and company share price.
In highly competitive markets, pharmaceutical companies need to understand:
- Did the data reveal resonate at the conference?
- Did it change the scientific conversation?
- Did the company gain share of voice?
- What’s the market sentiment?
- Did stakeholders see the company as an industry leader?
- Did the conference strengthen scientific authority and market influence?
- And ultimately, did the investment deliver a measurable return?
Until now, no dedicated solution existed to answer these questions.
See how SignalIQ answers them.
Illustrative demo · SignalIQ congress measurement
.The solution
Fusion brought the first dedicated congress measurement platform to market through SignalIQ.
By analysing share of voice, sentiment, message resonance, stakeholder influence and leadership perception, SignalIQ connects conference investment to measurable impact.
It answers one of the pharmaceutical industry’s toughest questions: what return is our meetings and events spend delivering?
The same proven methodology can be adapted to Arm’s business, stakeholder universe and priority events—revealing how events are landing, whether it is seen as an industry leader, where it is shaping the market and what return its event investment is generating.